{"name":"Reckitt Benckiser Inc.","slug":"reckitt-benckiser-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Algifor® Junior","genericName":"Algifor® Junior","slug":"algifor-junior","indication":"Other","status":"phase_1"},{"name":"Placebo of IR tablet","genericName":"Placebo of IR tablet","slug":"placebo-of-ir-tablet","indication":"Clinical trial control arm (Phase 3)","status":"phase_3"},{"name":"Placebo of PR tablet","genericName":"Placebo of PR tablet","slug":"placebo-of-pr-tablet","indication":"Other","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Mucinex®","genericName":"Mucinex®","slug":"mucinex","indication":"Productive cough due to bronchitis, common cold, or other respiratory conditions","status":"marketed"},{"name":"Mucinex® SE","genericName":"Mucinex® SE","slug":"mucinex-se","indication":"Productive cough due to bronchitis, common cold, or other respiratory conditions","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Nurofen Plus®","genericName":"Nurofen Plus®","slug":"nurofen-plus","indication":"Moderate acute pain (headache, dental pain, period pain, backache, minor injuries)","status":"phase_3"},{"name":"Panadeine® Extra","genericName":"Panadeine® Extra","slug":"panadeine-extra","indication":"Relief of moderate to severe pain","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ibuprofen Acid","genericName":"Ibuprofen Acid","slug":"ibuprofen-acid","indication":"Mild to moderate pain","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Immediate-release Guaifenesin","genericName":"Immediate-release Guaifenesin","slug":"immediate-release-guaifenesin","indication":"Acute bronchitis","status":"phase_2"}]}],"pipeline":[{"name":"Algifor® Junior","genericName":"Algifor® Junior","slug":"algifor-junior","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ibuprofen Acid","genericName":"Ibuprofen Acid","slug":"ibuprofen-acid","phase":"marketed","mechanism":"Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce the production of prostaglandins, thereby decreasing inflammation, pain, and fever.","indications":["Mild to moderate pain","Fever reduction","Inflammatory conditions (e.g., rheumatoid arthritis, osteoarthritis)"],"catalyst":""},{"name":"Immediate-release Guaifenesin","genericName":"Immediate-release Guaifenesin","slug":"immediate-release-guaifenesin","phase":"phase_2","mechanism":"Guaifenesin is an expectorant that works by increasing the volume and reducing the viscosity of respiratory tract secretions.","indications":["Acute bronchitis","Chronic bronchitis","Acute upper respiratory tract infections"],"catalyst":""},{"name":"Mucinex®","genericName":"Mucinex®","slug":"mucinex","phase":"marketed","mechanism":"Guaifenesin reduces mucus viscosity and promotes clearance of respiratory secretions by increasing hydration of mucus in the airways.","indications":["Productive cough due to bronchitis, common cold, or other respiratory conditions"],"catalyst":""},{"name":"Mucinex® SE","genericName":"Mucinex® SE","slug":"mucinex-se","phase":"marketed","mechanism":"Guaifenesin reduces mucus viscosity and promotes clearance of respiratory secretions to relieve chest congestion.","indications":["Productive cough due to bronchitis, common cold, or other respiratory conditions"],"catalyst":""},{"name":"Nurofen Plus®","genericName":"Nurofen Plus®","slug":"nurofen-plus","phase":"phase_3","mechanism":"Nurofen Plus combines ibuprofen (a nonsteroidal anti-inflammatory drug) with codeine phosphate (an opioid analgesic) to provide enhanced pain relief through dual analgesic and anti-inflammatory action.","indications":["Moderate acute pain (headache, dental pain, period pain, backache, minor injuries)"],"catalyst":""},{"name":"Panadeine® Extra","genericName":"Panadeine® Extra","slug":"panadeine-extra","phase":"phase_3","mechanism":"Panadeine Extra contains paracetamol and codeine, which work together to relieve pain and reduce fever.","indications":["Relief of moderate to severe pain","Reduction of fever"],"catalyst":""},{"name":"Placebo of IR tablet","genericName":"Placebo of IR tablet","slug":"placebo-of-ir-tablet","phase":"phase_3","mechanism":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","indications":["Clinical trial control arm (Phase 3)"],"catalyst":""},{"name":"Placebo of PR tablet","genericName":"Placebo of PR tablet","slug":"placebo-of-pr-tablet","phase":"phase_3","mechanism":"A placebo tablet contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQNUU1LTI1MExGNURsb05nTVNrU2tZU09GMW1NMnlnbjJfcWs4QjVTcTVJeXJTcnF6NDd6WFRpNkNPYlg5UkdmN1dWd3ExcUoxeWZhN2U1Nkc5S01kRmlSZlFxQUpQbWRQdkJyM1BKMEhOejdCOFQxbWFqV3FmTzlmSEFB?oc=5","date":"2026-02-23","type":"pipeline","source":"Yahoo Finance","summary":"Condom Market Report 2026-2035: A $22.57 Billion Industry by 2030 with Reckitt Benckiser, Church & Dwight, Humanwell Healthcare, Okamoto Industries, Mankind Pharma, Karex Berhad Leading - Yahoo Financ","headline":"Condom Market Report 2026-2035: A $22.57 Billion Industry by 2030 with Reckitt Benckiser, Church & Dwight, Humanwell Hea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQTnczWXBqTko3TWlGeXh2Z0pudWp0NnhZcHpRNnlpeGxfcTBMWWhmY2VhMFVSVkRyQWxSRVFiaVRMUUdyYk9xaEZFemVoaGtHY3A4ZjZwM3Mzd1BmQjVxOXJrYU9TeDZSZGdfRzh1cVZhMTRqYS1RSkxjMlJtd3pBN1RYVlNVUGxCbEx3SG5PVEVNdVYwYVlvLUxB?oc=5","date":"2025-08-07","type":"pipeline","source":"The New York Times","summary":"It Was a Promising Addiction Treatment. Many Patients Never Got It. - The New York Times","headline":"It Was a Promising Addiction Treatment. Many Patients Never Got It.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQY3gyZjc5V0ZHZkk0eFc0eGxLN2UzQVZBOXdkNlBKNnUzNTR6UXRabUNxbEFlb2kwRGhvakhTUkM4YUpZQTlhSlZsVV8takY1elZIeGRWdlFSMXFVbmtmeGVROHlTMmlRdFQ4MzB1aFBROGMtaWkyM3ZkQW5PaVNqeDRlLTRCMWg5Q1FMc29jenRrY3hTVHNRUmFXaE1pZw?oc=5","date":"2024-12-22","type":"pipeline","source":"Contract Pharma","summary":"Reckitt Benckiser to Spin Off its Pharma Businesses - Contract Pharma","headline":"Reckitt Benckiser to Spin Off its Pharma Businesses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNENOT21ZM09TRVpqUVJPdVo0ZUJmb25kX0FlazRuVDBwNEtMbW5fYU1Gd1JYSlRFZm52M0RxX1liYnpQTkFvZ3pqZjYtZ291RFVOM293clF1YXV5MUxCTko2TnZrd3RxMGdrc1FmcnhyMlZ3bldUbEZxeHExbTFJOFM3OHk0VFlPTWRqX0g5b1ZRdHpBMFFGQnpWLWN3MU9XZGpmU21zbmpYMWtjdTlPZVladzE4bVN1bmJMVC13d1JnQQ?oc=5","date":"2024-10-18","type":"pipeline","source":"Life Science Leader","summary":"Consumer Products Company Reckitt Investing $145M In Wilson Pharma Manufacturing Site - Life Science Leader","headline":"Consumer Products Company Reckitt Investing $145M In Wilson Pharma Manufacturing Site","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOMTBHa1ZBLVBNNzY0X2lUTWhwVEFRcl9idm05b2Q3dklfSDR1ckNCTDRoRno4X0NiT2h1ZTN5MTdzeGNxNjNidVVvTTRZLVBzMTRlSTZ5RHBIZGpKM1VlSk1tY015M0xzRVNBdzBCZnFManp2eDI1TEh2cERGOFBYZk5JOVZKREtjNTBPYzVTWHdUX1lURngxLWZCMUFiaHFqNmZWNHhKbmJTZTg2T1VjZjZtazl2VFhFT3lYNw?oc=5","date":"2024-09-24","type":"regulatory","source":"WRAL","summary":"Mucinex maker plans 289-job expansion in Wilson. NC approves $6.2M incentives package - WRAL","headline":"Mucinex maker plans 289-job expansion in Wilson. NC approves $6.2M incentives package","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNU0tZRXBEY3gtWEpYcFBKNnhXMmZfb1Q0QjBKNXVzdE1TR1I0dThzYVBxbmRIdW9ITzZjbVN6aVJ1LTZDN2tDSkdiMjNuQ2tTR0c0aV9IRkRla0l4TUxRVlA0aUFKM2pkREpvcVV4ZTRrRnozc3pDSlFDUmE5MlAtdnExZWdHTXRiR1J1TGlLSUYyLXQwV3BLU2NqUE9uOU43NVVrZGJxUXVCelF2Tkp1aURNTjl6Z3lOUFUwMDdJTm1jWWgx?oc=5","date":"2024-03-18","type":"deal","source":"The Guardian","summary":"Reckitt Benckiser: how one terrible deal wrecked the company - The Guardian","headline":"Reckitt Benckiser: how one terrible deal wrecked the company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQQm9GU0hDSGMzT2ROWWZVaWpaczJndGJMUW5wam5VUDJaR2RsYktYeGY2NzNzR2prSHU2ZUxKTWREMUEyWGVDeFdRamVwRlBZdEc2YUxaRUdPRGNJdUtPbWpQaVJISVFEaGpoSU0zWHgtLUhYX1RRQ1RCSThfcWtPTXo4T05DVHhwcjg2NDE3bkpTR0kyaHdpVUd0VTdxNjRTUmpCd0pib2c4emVXZWF5aVE0Smd4aFpiX3ZoM2pWelZSNFN6d1VZVFFCeU5fQ1BmUklwNTYyUXZHQQ?oc=5","date":"2023-11-23","type":"pipeline","source":"respiratory-therapy.com","summary":"Reckitt Benckiser Completes Purchase of Adams Respiratory Therapeutics Inc. - respiratory-therapy.com","headline":"Reckitt Benckiser Completes Purchase of Adams Respiratory Therapeutics Inc. - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNNElyNzN0ay1fb09pSXVSRzNHaHloQTBIbTYwWmtnM3lUdEh1R2ZMaEcza2U3dmFtZEVfSXBzak04UlNLSU1Lbmp6bHB0bGhGTVo1SzBkYkJnZTNYWi14dW1JZGYtT3haQ1BCOXI1NS01MXVHS2lTZ3g4Q2dRejNLcjNvNm1xTWdTQmF0MFEwS3B5dnE4cWJsaEdEVTVKVXRzZV9Na1ZjTUYzalktTWpvMFJKWmpoMVRUTHdV?oc=5","date":"2021-05-03","type":"pipeline","source":"NCDOJ (.gov)","summary":"Attorney General Josh Stein Announces $300 Million Settlement with Opioid Misuse Treatment Drug Maker - NCDOJ (.gov)","headline":"Attorney General Josh Stein Announces $300 Million Settlement with Opioid Misuse Treatment Drug Maker - NCDOJ (.gov)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQb3hJYUlIdU5mNFNVTkJLZWV4TUpMM3FIdFE0ZjNLelBTNVUtUUJ0dFRqM2FXOUdqWUdpbUFqeHZvZ3V0ell1aWNfeEh4MVpOREpoSXlXRUJGaTlxM2xQbm5HMENQWEx4N29idURFM28zc3NkMDh5a0FITFloTEJUQXBHeFhxdHNwNTVCbnFjMWlwQnhHRVp6b0VGcHhTbXAyRGNHWNIBqgFBVV95cUxPSkJYNWFTOVZNSU8xLVdKWmdtMTlDc21TMzFWZ2FzajZ5TjFNcWpUMC1sNFdKVHhudlRxREJYMDRXTTNYbVN4V3VMZ3JNR2ZWZFE3UEt5YXl2Z2JheDhmM1p2SmthX19KWEFnTWNnVkhWR0tHWEpfOFZxTE5mQklLVG16U0hpY1g1cGJaWG41VFBBLW1pYU92SXJnWElCTGtQYWpKRmwxQVY3QQ?oc=5","date":"2019-07-12","type":"pipeline","source":"ABC News","summary":"Suboxone maker Reckitt Benckiser to pay $1.4 billion in largest opioid settlement in US history - ABC News","headline":"Suboxone maker Reckitt Benckiser to pay $1.4 billion in largest opioid settlement in US history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBuYXNodnhPYVRqSV9WYW85R0RZckpYeUhfWnhReGRuVkpnanZSR29VbGhnRlVMRm1DVzJfSTBHc0FQZ0tJa2syUHMyNmdfUndNcktKUFB0RHU5V0ViQk9aczZXeTR6dTRlTVlIX0hmX0I?oc=5","date":"2019-04-14","type":"deal","source":"Financial Times","summary":"Purdue tried to buy Reckitt Benckiser’s addiction business - Financial Times","headline":"Purdue tried to buy Reckitt Benckiser’s addiction business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPcW1ia1dKRkVyVEw2dElWVXBxdVN5WnhNVWhsbWZ6YUVqYk1uVDJueVVmNnNzSm9WUDY0QjNVY0pOUFNnb19ESGJfNjBsU1R1SW9YWlZWX1ZDd2NhaDJ6OUxCSG5QNjdrUnNpdVl6U0ZUcVJpczdPcHFtc21rcjJJVC05ZzN4dlhzOE5tdzVwMkpQMzAxSzdLYlFPQmY?oc=5","date":"2014-07-28","type":"pipeline","source":"BioPharma Dive","summary":"Reckitt Benckiser to spin off pharmaceutical business - BioPharma Dive","headline":"Reckitt Benckiser to spin off pharmaceutical business","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_1":1,"marketed":3,"phase_2":1,"phase_3":4},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}